FitLife Brands, Inc. — Form 10-Q Summary
Business Context and Reporting Period
FitLife Brands, Inc. develops and sells nutritional supplements under the NDS and iSatori brand families. Products are distributed primarily through GNC, more than 17,000 retail locations, and online channels. The report covers the three and six months ended June 30, 2022; comparative 2021 information was restated.
- Common stock trades over the counter under ticker FTLF.
- GNC represented 70% of revenue in both the quarter and six-month period ended June 30, 2022.
- Online sales represented approximately 26% of quarterly and year-to-date revenue, up from 21% and 24%, respectively, in the comparable periods.
Financial Performance and Liquidity
| Metric | Q2 2022 | Q2 2021 | Change | Six months 2022 | Six months 2021 |
|---|---|---|---|---|---|
| Revenue | $7.999 million | $8.406 million | -5% | $15.454 million | $14.005 million |
| Gross profit | $3.665 million | $3.681 million | Flat | $6.937 million | $6.476 million |
| Gross margin | 45.8% | 43.8% | +200 bps | 44.9% | 46.2% |
| Operating income | $1.825 million | $2.033 million | -10% | $3.421 million | $3.294 million |
| Net income | $1.446 million | $1.632 million | -11% | $2.736 million | $3.037 million |
| Diluted EPS | $0.29 | $0.34 | -15% | $0.55 | $0.64 |
| Operating cash flow | Not separately provided | Not separately provided | — | $2.378 million | $3.008 million |
Quarterly operating and net margins were approximately 22.8% and 18.1%, respectively. Six-month operating and net margins were approximately 22.1% and 17.7%.
- Cash was $12.304 million at June 30, 2022, compared with $9.897 million at December 31, 2021.
- Working capital was approximately $17.320 million, compared with $13.626 million at year-end 2021.
- Accounts receivable was $2.122 million and inventory was $6.348 million.
- Total liabilities were $4.040 million, consisting primarily of operating lease liabilities; no borrowings were outstanding under the $2.5 million revolving credit facility.
- The revolving credit facility was extended after quarter-end to December 23, 2022. It is secured by company assets and bears interest at one-month LIBOR plus 2.75% when drawn.
- Cash increased by $2.407 million during the six months, principally from operating cash flow. There was no investing cash outflow in 2022.
Material Changes Versus the Prior Comparable Period
- Second-quarter revenue declined 5%, reflecting timing fluctuations in wholesale customer orders. Six-month revenue increased 10%, driven by wholesale and online sales.
- Second-quarter gross margin improved because of a manufacturer rebate and a higher online-sales mix. Year-to-date gross margin declined because of higher product costs associated with supply-chain disruptions.
- General and administrative expense increased 12% in the quarter and 21% year to date, including $203,000 of abandoned transaction-related M&A costs in the quarter, $208,000 year to date, and $55,000 of restatement-related professional fees.
- Year-to-date net income declined 10%, partly because the prior-year period included a $453,000 gain from PPP loan forgiveness.
- Operating cash flow declined from $3.008 million to $2.378 million because of increased working-capital needs, including higher accounts receivable.
Guidance, Outlook, Risks, and Unusual Items
- Management expects cash from operations, existing cash, and available revolver capacity to support liquidity for the next twelve months, but states that no assurance can be given.
- Management expects online revenue to continue increasing relative to prior periods and views online sales as higher margin, although no formal revenue or earnings guidance was provided.
- Inflation has increased product procurement costs; the company has so far offset the impact through price increases, but future pass-through may be limited.
- COVID-19-related retail closures, supply-chain disruptions, manufacturing lead times, reduced demand, and potential goodwill impairment remain risks.
- The company filed Form 15 in July 2022 to deregister its common stock and terminate periodic reporting obligations, but stated that it intends to withdraw the filing after returning to current filer status.
- Previously issued financial statements for specified 2019, 2020, and 2021 periods were determined to require restatement because revenue under FOB destination terms was recognized at shipment rather than delivery. The errors also affected receivables, inventory, cost of goods sold, taxes, and cash flows.
- Management concluded that disclosure controls and internal control over financial reporting were ineffective as of June 30, 2022 because of material weaknesses involving the control environment, risk oversight, control activities, information processing, communication, and monitoring. Remediation includes outside accounting consultants and a new CFO hired in August 2022.
- No material litigation or material defaults were reported.
Most Important Facts for Investors to Verify
- Confirm the status and scope of the revenue-recognition restatement and whether remediation of material weaknesses has been completed.
- Assess concentration risk from GNC, which accounted for 70% of revenue and 77% of gross accounts receivable at June 30, 2022.
- Verify the company’s ability to maintain revenue growth and margins amid supply-chain costs, inflation, and reliance on wholesale order timing.
- Review the revolving credit facility’s post-quarter-end extension and availability under its financial and operational terms.
- Evaluate the sustainability of reported earnings excluding the prior-year PPP forgiveness gain and current-period M&A and restatement costs.
- Confirm the status of the Form 15 deregistration and the company’s ongoing SEC reporting obligations.